Well-placed sources said the larger English study found hospitalisation rates in over-70s were slightly lower among recipients of the Oxford vaccine than those who got the Pfizer drug. Last month, German authorities advised against using the Oxford vaccine in over-65s, citing lack of evidence of effectiveness from formal trials. Last night it emerged that Germany is reconsidering its recommendation on the Oxford vaccine. French President Emmanuel Macron initially questioned the AstraZeneca vaccine, but last week admitted that ‘the efficacy of the AstraZeneca vaccine has been proven’. Macron has claimed that he would take the Oxford jab if he were offered it – a radical change of stance.

Source: The Nation February 27, 2021 22:52 UTC